Human papilloma virus vaccine induced thrombocytopenia accompanied by a wide spectrum of reversible inflammatory responses - a case report

S Holm; A E Michelsen; N H Schultz; T Ueland; H Reikvam; P A Holme; P Aukrust; B Halvorsen

doi:10.1080/00365513.2024.2400663

Human papilloma virus vaccine induced thrombocytopenia accompanied by a wide spectrum of reversible inflammatory responses - a case report

Scand J Clin Lab Invest. 2024 Sep 12:1-3. doi: 10.1080/00365513.2024.2400663. Online ahead of print.

Authors

S Holm¹, A E Michelsen^{1

2}, N H Schultz^{1

3}, T Ueland^{1

2

4}, H Reikvam^{5

6}, P A Holme^{1

2

3}, P Aukrust^{1

2

7}, B Halvorsen^{1

2

8}

Affiliations

¹ Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.
² Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
³ Department of Haematology, Oslo University Hospital, Oslo, Norway.
⁴ Department of Clinical Medicine, Thrombosis Research and Expertise Center, UiT-The Arctic University of Norway, Tromsø, Norway.
⁵ Department of Clinical Science, University of Bergen, Bergen, Norway.
⁶ Department of Medicine, Haukeland University Hospital, Bergen, Norway.
⁷ Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway.
⁸ Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

PMID: 39264796
DOI: 10.1080/00365513.2024.2400663

No abstract available

Keywords: HPV; VITT; neutrophil; thrombocytopenia; thrombosis; vaccine.